One year of the Sussex Cancer Research Centre

One year ago, with support from a large community of researchers, health care professionals and people with experience of cancer, we launched the Sussex Cancer Research Centre (SCRC). Our central aim is to bring together cancer scientists, clinicians, allied health professionals, and people with lived experience to pioneer interdisciplinary research that improves treatment and outcomes for people with cancer.

We draw on expertise from Brighton and Sussex Medical School (BSMS), the Universities of Brighton and Sussex, University Hospitals Sussex NHS Foundation Trust (UHSx), neighbouring hospitals, and industry partners. Importantly, our work is shaped at every level by people impacted by cancer.

So, one year on—how are we doing?


Our goals for year one

At the launch of the SCRC, together we set out the below aims for the centre. Click on each aim to read how we are delivering on our shared vision.


New and emerging research themes, united by the Sussex Cancer Research Centre.

The SCRC is builing on a strong foundation, with existing research strengths including:

As we unite researchers across Sussex a number of new and exciting research strengths have emerged. These were driven by feedback from those with lived-experience of cancer who shape our research priorities.

Sussex Cancer-Related Fatigue Group

Sussex Brain Tumour Research Group


You shaped the Sussex Cancer Research Centre

At our launch last year, we asked you: what are the biggest challenges or missed opportunities for cancer research in Sussex?

Live feedback during the SCRC launch event was supplemented by offline feedback in the weeks following the launch.

Top of the list was funding—especially the difficulty in accessing funding across institutional boundaries. This year, we pump-primed five new cross-institutional research projects. These were selected for their scientific excellence, potential impact, and capacity to join the dots on the bench-to-bedside cancer research landscape across Sussex.

Another top priority was funding more PhD studentships. This year, we funded three PhD projects. We are proud to have been able to support both innovative research and three new research careers here in Sussex.

Read all about our funded research projects here.

The collaborative networks enabled by SCRC funding in our first year: Each arrow represents collaborations between institutions that were funded by the SCRC in its first year.


Thank you

None of this year’s progress would be possible without all of your ideas, engagement, support, vision, and generosity. Generous support from our institutions, visionary philanthropic support, and a strong partnership with the Sussex Cancer Fund have been essential for the success of the SCRC and all the research progress it is enabling. Thank you.


Looking Ahead

We have a number of exciting updates to share as the SCRC continues to grow, shaped by your input:

We’ve also identified the following priorities for the years ahead:

  • Initiate further themed meetings

  • Seek further funding for:

    • PhD studentships, including external funding for doctoral training programmes/centres.

    • Pump-priming projects.

    • Externally-funded programme grants.

  • Elevate status at universities to Centre of (Research) Excellence

  • Facilitate more bench to bedside research through embedding of research resources, space, and expertise in new clinical research facilities.

  • Support/mentor SCRC researcher applications for external funding.

  • Increase awareness, fundraising, and engagement with the SCRC by fully implementing our inclusive community engagement plan.

We want you to help shape our plans for the next year.

The years ahead have the potential to have a positive impact on our research, our communities, and people with cancer across Sussex. We can only achieve these goals with your support.

Please consider making a charitable donation to the Sussex Cancer Research Centre.

Previous
Previous

New SCF/SCRC pump-priming awards open for applications.

Next
Next

Sussex scientists find ‘off switch’ that could turbo-charge cancer immunotherapy and prolong lives.